ARTBIO is a clinical-stage radiopharmaceutical company focused on developing a new class of alpha radioligand therapies (ARTs) to transform cancer treatment. ARTBIO's approach centers on utilizing the alpha-emitting isotope Pb212 to target cancer cells while minimizing damage to healthy tissues.
Member of the Swiss Biotech Association
Member
ArtBio GmbH
ArtBio GmbH
Verified listing
-
Founded2022
-
Employees in Switzerland10-19
- Send an email
- Get directions
- Bookmark
- Share
- Report
- prev
- next